USPTO serial 99466281
NOVAGO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 1, 2026
- Examiner
- CHADAB, SETH WILLIG
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NOVAGO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janice Housey
Janice Housey Litmus Law PLLC4 Weems Lane #240Winchester, VA 22601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for use in the development of biologics, specifically therapeutic antibodies; Chemical preparations for general industrial manufacturing purposes; chemical preparations for scientific use other than for medical or veterinary use; chemical preparations for photography; biological materials other than for medical or veterinary purposes for use in the manufacture of biologics, specifically therapeutic antibodies; biological preparations, namely, biologics, specifically therapeutic antibodies other than for medical or veterinary use; Chemical products in the nature of peptides for manufacture of chemical products and foodstuffs; polypeptides in the nature of biochemical preparations for scientific use; Biochemicals, namely, antibodies and proteins for scientific use | ACTIVE | — |
| 005 | Pharmaceutical preparations for treatment of central and peripheral nervous system injuries; preparations for immunotherapeutic purposes related to diseases of the immune system; Pharmaceutical products for the suppression of tumors; Pharmaceutical preparations for neurodegenerative diseases; Pharmaceutical products being immunogens for medical use; vaccines, antibodies for medical purposes, epitopes for pharmaceutical use; Synthetic peptides for pharmaceutical purposes; sanitary preparations for medical use; biological preparations for use in cell cultures for medical use; biocides; diagnostic products being diagnostic agents for medical use; towels for hygiene purposes, namely, wipes impregnated with disinfectants for hygiene purposes; dietetic foods for medical use; dietetic beverages for medical use; protein antibodies for medical purposes | ACTIVE | — |
| 042 | Monitoring and inspection for the quality control and analysis of active substances, as well as research involving pharmaceutical products, cosmetics or foodstuffs; consultancy and information on monitoring and inspection for the quality control and analysis of active substances, as well as research involving pharmaceutical products, cosmetics or foodstuffs; monitoring and inspection for the quality control and analysis of active substances, as well as research involving medical treatment and methods; research in the fields of biotechnology and antibodies; Providing information on monitoring and inspection for the quality control and analysis of active substance testing and research in technical and medical treatment; Providing research in the field of sanitary care; monitoring, inspection for quality control of pharmaceutical products and research in the field of biology; computer software design, computer programming; design and development of computer hardware; software development; consultancy and provision of information relating to quality control of pharmaceutical preparations; software maintenance | ACTIVE | — |
| 044 | Medical services; medical services in the field of immunity; provision of medical information; medical examinations; preparation and dispensing of medicines; consultancy and provision of information in the field of sanitary care; health care; consultancy and provision of information relating to the operation, preparation, dispensing and dosage of pharmaceutical preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NovaGo Therapeutics AG
- Other trademarks owned by NovaGo Therapeutics AG
- Other trademarks owned by NovaGo Therapeutics AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named NOVAGO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 1, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 1, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 14, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 14, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 8, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 18, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 16, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 16, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 16, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 20, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 11, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 28, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 28, 2025 | NWAP | NEW APPLICATION ENTERED | — |